Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons

MR D'Andrea, RG Nagele - Current pharmaceutical design, 2006 - ingentaconnect.com
Although there is still no known effective preventative treatment or cure for Alzheimer's
disease (AD), the development of new drugs that target pathological features that appear …

Targeting the Alpha 7 Nicotinic Acetylcholine Receptor to Reduce Amyloid Accumulation in Alzheimer's Disease Pyramidal Neurons

MR D'Andrea, RG Nagele - Current Pharmaceutical Design, 2006 - search.proquest.com
Although there is still no known effective preventative treatment or cure for Alzheimer's
disease (AD), the development of new drugs that target pathological features that appear …

[引用][C] Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amy loid accumulation in alzheimer's disease pyramidal neurons: Drug Targets in Alzheimer's …

MR D'ANDREA, RG NAGELE - Current pharmaceutical design, 2006 - pascal-francis.inist.fr
Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amy loid accumulation in
alzheimer's disease pyramidal neurons : Drug Targets in Alzheimer's Disease CNRS Inist …

[PDF][PDF] Targeting the Alpha 7 Nicotinic Acetylcholine Receptor to Reduce Amy-loid Accumulation in Alzheimer's Disease Pyramidal Neurons

MR D'Andrea, RG Nagele - Current Pharmaceutical Design, 2006 - researchgate.net
Although there is still no known effective preventative treatment or cure for Alzheimer's
disease (AD), the development of new drugs that target pathological features that appear …

Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons

MR D'Andrea, RG Nagele - Current Pharmaceutical Design, 2006 - researchwithrowan.com
Although there is still no known effective preventative treatment or cure for Alzheimer's
disease (AD), the development of new drugs that target pathological features that appear …

[引用][C] Targeting the Alpha 7 Nicotinic Acetylcholine Receptor to Reduce Amyloid Accumulation in Alzheimers Disease Pyramidal Neurons

M D'Andrea, R Nagele - Current Pharmaceutical Design, 2006 - cir.nii.ac.jp
Targeting the Alpha 7 Nicotinic Acetylcholine Receptor to Reduce Amyloid Accumulation in
Alzheimers Disease Pyramidal Neurons | CiNii Research CiNii 国立情報学研究所 学術情報 …

Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.

MR D'Andrea, RG Nagele - Current Pharmaceutical Design, 2006 - europepmc.org
Although there is still no known effective preventative treatment or cure for Alzheimer's
disease (AD), the development of new drugs that target pathological features that appear …

Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons

MR D'Andrea, RG Nagele - Current pharmaceutical …, 2006 - pubmed.ncbi.nlm.nih.gov
Although there is still no known effective preventative treatment or cure for Alzheimer's
disease (AD), the development of new drugs that target pathological features that appear …

[PDF][PDF] Targeting the Alpha 7 Nicotinic Acetylcholine Receptor to Reduce Amy-loid Accumulation in Alzheimer's Disease Pyramidal Neurons

MR D'Andrea, RG Nagele - Current Pharmaceutical Design, 2006 - researchgate.net
Although there is still no known effective preventative treatment or cure for Alzheimer's
disease (AD), the development of new drugs that target pathological features that appear …